News · Colgate-Palmolive Company (CL) · Consumer Defensive

Colgate-Palmolive rises 2.2% as the consumer defensive sector gains

Session of November 2, 2026 · Published November 3, 2026 · 3 min read

What happened

Colgate-Palmolive (CL) rose 2.2% on November 2, 2026, as the Consumer Defensive sector median rose 1.8%, a move driven by sector momentum rather than company-specific news. The stock opened 1.1% above the previous close and finished at a closing price of $97.43 on volume that was 1.0 times its 20-day average. The S&P 500 fell 0.5% on the day; the stock outperformed its sector by 0.4 percentage points and posted a five-session gain of 4.7% while the S&P 500 fell 1.8% over the same span.

$85.00$90.00$95.00Sep 22Oct 1Oct 12Oct 22Nov 2CL closing price, last 30 sessionspromtfinance.com$97.43 (+2.2%)
Closing price over the last 30 trading sessions. On November 2, 2026, CL closed at $97.43, up 2.2% on the day and 11.9% higher than 30 sessions earlier.

How big was the move

The one-day rise of 2.2% was 1.7 times a typical daily move for the stock and matched the direction of the sector, supporting the view that the move was sector-wide. Trading volume was in line with recent activity, indicating no extreme departure from normal liquidity. The stock’s market sensitivity is low with a beta of 0.15, meaning the stock tends to move less than the market. In the past five years there were 35 sessions with a gain of at least 2.2%; twenty trading days later the median result was a decline of 0.7%, and 17 of 35 were higher.

-2%0%+2%Aug 10Sep 8Oct 5Nov 2CL daily moves, last 60 sessions2 std. dev. bandpromtfinance.com
Each bar is one day's price change; the outlined bar is November 2, 2026. A typical daily move over the past year was 1.5%, so the latest move equals 1.5 times that. Moves outside the dashed lines (about 2.9%) are unusual.

The technical picture

The stock was 5.6% above its 20-day moving average and 8.6% above its 50-day average, and it was 8.6% above its 200-day average at the close. The stock had spent 16 consecutive trading days above the 200-day average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend despite the recent rally. The Relative Strength Index (14 days) was 66, which sits between 30 and 70, a neutral range. Shorter-term momentum looked healthy: the change over one month rose 15.6% and the change over three months rose 5.3%. The stock was 1.9% below its 52-week high at the close.

$80.00$90.00$100.00Oct '25Feb '26May '26Aug '26Nov '26CL one-year price and moving averages200-day50-dayPricepromtfinance.com52-week high $99.1452-week low $74.98
Closing price over the past year. CL ends the period 1.7% below its 52-week high, above its 50-day average ($89.68) and above its 200-day average ($89.75).

Volatility was elevated relative to its recent history, at 21% annualized over 60 days, which is higher than 75% of its own readings over five years. That suggests larger-than-usual swings for the stock compared with its history.

Fundamentals and valuation

For the four quarters through September 30, 2026, revenue was $21.28 billion, which grew 5.9% from a year earlier. Diluted earnings per share for that period were $2.55, and earnings per share growth from a year earlier fell 28.5%. Gross margin was 60.6% compared with 60.2% a year earlier, while operating margin was 20.5% versus 21.6% a year earlier. Free-cash-flow margin was 17.8% and return on invested capital was 29.9%. The balance sheet showed net debt of 1.6 times EBITDA, and share count over one year decreased by 1.4%.

$0.00$2.0B$4.0BQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26CL quarterly revenuepromtfinance.com$4.9B$4.9B$5.1B$5.1B$5.2B$5.3B$5.4B$5.4B
Quarterly revenue by period end. The latest quarter brought $5.4B, 4.6% more than the same quarter a year earlier.

Valuation remains rich. Price to trailing earnings is 38.1 times trailing earnings, a figure that is higher than 90% of its own readings over the past five years (five-year median: 31.8 times earnings). Price to forward earnings is 25.3 times expected earnings and free-cash-flow yield stood at 5.0%. PromtFinance scores rank Colgate-Palmolive as Value 12 (Very weak), Growth 53 (Neutral), Quality 99 (Exceptional), Momentum 81 (Strong), Revisions 51 (Neutral) and Stability 89 (Strong).

Earnings and analyst expectations

The company last reported on October 30, 2026, with earnings per share of $0.97 against $0.93 expected, 4.8% above estimates. That marked the 15th consecutive quarter beating estimates, and the average surprise over the last four reports was 4.1% above estimates. Typical two-day reaction after recent reports has been modest, with the stock rising 0.9% on average. The next report is scheduled for January 29, 2027.

$0.00$0.50Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26CL quarterly earnings per sharepromtfinance.com$0.90$0.85$0.91$0.91-$0.05$0.80$0.86$0.94
Diluted earnings per share by quarter. The latest quarter shows $0.94, against $0.91 in the same quarter a year earlier.

Analysts offer a consensus rating of Hold with 45 analysts covering the stock. The consensus price target is $100.14, which is 2.8% above the closing price, and 40% of analysts rate the stock Buy or Strong Buy.

What to watch

  • October 30, 2026: last report — earnings per share of $0.97 against $0.93 expected, 4.8% above estimates
  • January 29, 2027: next scheduled earnings report
  • Price to trailing earnings: 38.1 times trailing earnings, higher than 90% of its readings over the past five years
  • Time above the 200-day average: 16 consecutive trading days
  • Change over one month: rose 15.6%

Related stocks

More news from PromtFinance

Related stories from the last 48 hours

COSTConsumer DefensiveNov 2Costco rises with Consumer Defensive sector as dividend date nearsCostco rose 2.8% on November 2, 2026, with volume 1.4 times its 20-day average; the company is due to pay a final quarterly dividend on November 13, 2026.Read the analysis →ELConsumer DefensiveNov 2Estée Lauder Companies falls 4.1% after quarterly earnings beat and raised guidanceEstée Lauder fell 4.1% on Nov. 2 after fiscal Q1 results beat estimates and management raised its fiscal 2027 outlook, with fragrance sales driving margin gains.Read the analysis →AMZNConsumer CyclicalNov 2Amazon rises 2.2% as sector strength and AWS-driven earnings news lift the stockAmazon rises 2.2% on November 2, 2026, in a sector-wide upswing after strong AWS results and analyst activity following the company's earnings report.Read the analysis →ABTHealthcareNov 2Abbott rises after positive Amulet 360 study resultsAbbott rose 3.7% on November 2, 2026, after the VERITAS study showed strong Amulet 360 closure and low stroke incidence.Read the analysis →SOLVHealthcareNov 2Solventum rises after acquisition of ASB Energy Services expands infrastructure capabilitiesSolventum rose 4.2% on November 2, 2026, after completing the ASB Energy Services acquisition; trading outperformed the healthcare sector.Read the analysis →MSFTTechnologyNov 2Microsoft falls 2.8% as technology sector pulls stocks lowerMicrosoft fell 2.8% on November 2, 2026, moving with the technology sector after sector weakness outweighed recent strong cloud results.Read the analysis →CVXEnergyNov 2Chevron falls 3.3% as energy sector retreats despite strong fundamentalsChevron fell 3.3% on Nov. 2, 2026, tracking a sector decline while recent earnings beats and momentum keep long-term technicals and fundamentals strong.Read the analysis →